These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8415245)

  • 1. [Captopril treatment--2-year period of observation].
    Tkaczewski W; Adamska-Dyniewska H; Bała T; Gajewska B; Chojnowska-Jezierska J; Rosiek S; Słomka S
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):318-20. PubMed ID: 8415245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative assessment of digoxin and captopril in the treatment of chronic congestive circulatory failure, NYHA grade II].
    Lehmann Z; Wierzchowiecki M; Michalski M; Stasiński T; Ozegowski S
    Wiad Lek; 1994 Aug; 47(15-16):574-8. PubMed ID: 7716952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Captopril versus digoxin in the treatment of mild to moderately severe heart failure].
    Heck I; Müller HM; Esser H; Lüderitz B
    Dtsch Med Wochenschr; 1989 May; 114(18):695-9. PubMed ID: 2653765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of captopril levels in chronic congestive heart failure, stages NYHA III and IV].
    Mazur-Cichocka M; Michałowicz B; Stasiński T; Wierzchowiecki M
    Pol Tyg Lek; 1991 May 6-20; 46(19-21):375-9. PubMed ID: 1845677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of captopril in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Nicolin M; Streian C
    Med Interne; 1989; 27(2):99-105. PubMed ID: 2683008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [When does the treatment with captopril show a better improvement in physical performance in patients with heart failure?].
    Canesin MF; Barretto AC; Oliveira Júnior MT; Bodanese LC; Marafon P; Arsencio SR
    Arq Bras Cardiol; 1996 Aug; 67(2):77-80. PubMed ID: 9110437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term results of heart transplantation, cardiomyoplasty, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy.
    Bocchi EA; Bellotti G; Moreira LF; Bacal F; de Moraes AV; Fiorelli A; Mansur A; Stolf N; Jatene A; Pileggi F
    J Heart Lung Transplant; 1996 Jul; 15(7):736-45. PubMed ID: 8820791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and medium term results of tailored therapy for heart failure.
    Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
    Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
    Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
    Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical predictors of left ventricular function improvement after percutaneous coronary interventions in patients with ejection fraction below 45%].
    Dudek D; Rzeszutko Ł; Turek P; Sorysz D; Dubiel JS
    Przegl Lek; 2001; 58(7-8):751-4. PubMed ID: 11769380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.